Grupo Mateus Q4 2025 slides: expansion drives growth, margins pressured

Shares plunged 12.78% to R$4.11 after Q4 2025 EPS of 0.1534 (missed estimates by 12.74%) and same-store sales fell 1.1%. Q4 revenue was R$12.1bn (+21.8% YoY) and full-year R$43.6bn (+19.7%); gross margin expanded 70bps to 22.5% but operating expenses jumped 34.2%, driving Q4 EBITDA margin down 100bps to 6.2% (EBITDA R$652m). Net debt improved to R$1.059bn (net debt/EBITDA 0.41x) and CAPEX was R$1.023bn, yet investors remain concerned about margin sustainability amid 22 new stores (total 302) and negative same-store sales; forward P/E ~5.29 and Q1-2026 EPS forecast $0.07 on ~$1.84bn revenue.

Analysis

The market is treating the company’s growth phase as a pure multiple-compression problem, but the real binary sits in execution of scale — specifically ERP/back-office integration and store ramp economics. A failed systems rollout or slower-than-expected productivity gains will keep margins depressed for 2–4 quarters and create a visible working-capital and earnings hit; conversely, a clean integration would unlock significant operating leverage over the following 4–12 quarters.

Second-order winners include regional competitors with cleaner balance sheets and lower new-store churn who can selectively invest to take share in mature catchment areas; food manufacturers and distributors with high receivables concentration to the company are exposed to payment timing volatility and may tighten trade terms, pressuring the company’s inventory turns. Real estate owners and smaller rivals could pick up underperforming locations at attractive valuations if strategic retrenchment occurs.

Key catalysts to watch: the ERP go-live status and first-month post‑go-live sales/stockouts (days/weeks), sequential same-store-sales inflection over the next two quarters, and any management actions to slow openings or pivot formats (months). Tail risks include a botched systems implementation or a sudden tightening of consumer credit in the company’s regional markets — both could compress EPS materially within one quarter.

Contrarian angle: headline selling likely overstates medium-term insolvency risk because leverage optionality exists; if management pivots to slower openings and demonstrates 2 consecutive quarters of margin recovery, the stock can re-rate quickly. The investment is therefore binary and time-sensitive — treat positions as event-driven, not buy-and-hold.

Key Decisions for Investors

• Initiate a tactical short on GMAT3 (B3:GMAT3) sized 1–2% of portfolio with a 6–12 month horizon. Target 30–40% downside; hard stop at 20% adverse move. Rationale: execution/system risk and margin dilution are likely to play out within two quarters.
• Pair trade: short GMAT3 / long ASAI3 (B3:ASAI3) at a 1:0.6 notional ratio to approximate beta-neutral exposure for 3–9 months. Expect asymmetric payoff if GMAT3’s SSS trend deteriorates while Assaí captures share; cut the pair if the spread tightens by 15% intraday or one counter issues material operational guidance.
• Buy a defensive options spread on GMAT3 to limit premium: buy 9–12 month puts 30% OTM and sell puts 50% OTM (ratio 1:1). Max loss = premium paid; max gain realized if shares gap lower through sold strike — cost-efficient tail hedge if holding regional retail exposure.
• Contrarian selective long: allocate a small (0.5–1%) position to long-dated calls (18–24 months) or outright equity only after management announces a clear slowdown in new openings and posts two sequential quarters of margin improvement. Target 3x+ upside if execution evidence appears; stop-loss at 30%.